GCR is asking in-house antitrust counsel about any potential collaboration concerns they have as they respond to the coronavirus pandemic.
GCR has launched a survey to investigate how concerned companies are about cooperating with their competitors during the covid-19 pandemic. The short survey aims to gauge the type of collaboration that companies have agreed to; if they sought and received prior approval from the relevant competition authority; and if the collaboration will be easy to unwind once markets return to normal.
The survey also asks if companies are concerned about increased enforcement risks as a result.
As antitrust authorities around the world react to the covid-19 pandemic, they have relaxed competition rules in certain jurisdictions to help companies cooperate to meet increased demand and to cope with supply shortages.
In March, the UK’s Competition and Markets Authority relaxed competition rules allowing retailers to cooperate. The US antitrust agencies issued a joint statement promising a quick turnaround when reviewing cooperation between rivals to combat the covid-19 pandemic.
The European Commission also issued a rare guidance letter in April approving a pharmaceutical cooperation scheme. It clarified new rules permitting collaboration between rivals to ensure the supply of essential products during the pandemic.
Meanwhile, the Australian Competition and Consumer Commission has been one of the most active enforcers in blessing collaboration agreements since the pandemic began, approving agreements in sectors such as healthcare, insurance and fuel.
The deadline to complete the survey is 15 June. The survey should take no longer than 10 minutes to complete.
Please click here to participate.